ClinicalTrials.Veeva

Menu
Innovation Medical Research Center | Miami, FL logo

Innovation Medical Research Center | Miami, FL

Research site

Site insights

Top conditions

Top treatments

AVP-786
ABP-450
Bardoxolone Methyl
Lansoprazole
Vonoprazan
Rocatinlimab
Cenicriviroc
PF-06865571
progestin
Obeticholic Acid

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Albert Garcia

Verified by this site

Active trials

9 of 39 total trials

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND)

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in t...

Enrolling
COVID-19 SARS-CoV-2 Infection
Drug: placebo
Drug: ibuzatrelvir

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People ca...

Enrolling
Heart Failure
Drug: Placebo matching vicadrostat
Drug: Empagliflozin

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripher...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Placebo (matched to pregabalin)
Drug: Placebo (matched to VX-993)

This study is open to adults who are at least 18 years old and have:* A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or* A con...

Enrolling
Metabolic Dysfunction Associated Steatohepatitis
Drug: Survodutide
Drug: Placebo matching survodutide

This study is open to adults who are at least 18 years old and have:* a confirmed liver disease called non-alcoholic steatohepatitis (NASH)/metabolic...

Enrolling
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Liver Fibrosis
Drug: Survodutide
Drug: Placebo

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with...

Enrolling
Irritable Bowel Syndrome with Diarrhea
Drug: CIN-103
Drug: Placebo

Primary Objective:Primary population (former smokers cohort):* Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of ac...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab SAR440340

The Sponsor is developing a progestin-only contraceptive transdermal system (patch).The main purpose of this study is to look at how safe the study p...

Enrolling
Female Contraception
Drug: Transdermal system containing progestin

Trial sponsors

Pfizer logo
Boehringer Ingelheim logo
Moderna logo
A
Amgen logo
BioNTech logo
Biogen logo
N
Otsuka logo
Phathom Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems